Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes

Glycans play a fundamental role in several biological processes, such as cell–cell adhesion, signaling, and recognition. Similarly, abnormal glycosylation is involved in many pathological processes, among which include tumor growth and progression. Several highly glycosylated proteins found in blood...

Full description

Bibliographic Details
Main Authors: Andrea Ragusa, Pietrina Romano, Marcello Salvatore Lenucci, Emanuela Civino, Daniele Vergara, Elena Pitotti, Cosimo Neglia, Alessandro Distante, Giampiero Diego Romano, Nicola Di Renzo, Giammarco Surico, Prisco Piscitelli, Michele Maffia
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/11/9/566
_version_ 1797518270325063680
author Andrea Ragusa
Pietrina Romano
Marcello Salvatore Lenucci
Emanuela Civino
Daniele Vergara
Elena Pitotti
Cosimo Neglia
Alessandro Distante
Giampiero Diego Romano
Nicola Di Renzo
Giammarco Surico
Prisco Piscitelli
Michele Maffia
author_facet Andrea Ragusa
Pietrina Romano
Marcello Salvatore Lenucci
Emanuela Civino
Daniele Vergara
Elena Pitotti
Cosimo Neglia
Alessandro Distante
Giampiero Diego Romano
Nicola Di Renzo
Giammarco Surico
Prisco Piscitelli
Michele Maffia
author_sort Andrea Ragusa
collection DOAJ
description Glycans play a fundamental role in several biological processes, such as cell–cell adhesion, signaling, and recognition. Similarly, abnormal glycosylation is involved in many pathological processes, among which include tumor growth and progression. Several highly glycosylated proteins found in blood are currently used in clinical practice as cancer biomarkers (e.g., CA125, PSA, and CA19-9). The development of novel non-invasive diagnostic procedures would greatly simplify the screening and discovery of pathologies at an early stage, thus also allowing for simpler treatment and a higher success rate. In this observational study carried out on 68 subjects diagnosed with either breast or lung cancer and 34 healthy volunteers, we hydrolyzed the glycoproteins in saliva and quantified the obtained free sugars (fucose, mannose, galactose, glucosamine, and galactosamine) by using high-performance anion-exchange chromatography with pulsed-amperometric detection (HPAEC-PAD). The glycosidic profiles were compared by using multivariate statistical analysis, showing differential glycosylation patterns among the three categories. Furthermore, Receiver Operating Characteristics (ROC) analysis allowed obtaining a reliable and minimally invasive protocol able to discriminate between healthy and pathological subjects.
first_indexed 2024-03-10T07:27:31Z
format Article
id doaj.art-e80b1748ffcb4e6f9566366722483936
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-10T07:27:31Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-e80b1748ffcb4e6f95663667224839362023-11-22T14:11:01ZengMDPI AGMetabolites2218-19892021-08-0111956610.3390/metabo11090566Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic PurposesAndrea Ragusa0Pietrina Romano1Marcello Salvatore Lenucci2Emanuela Civino3Daniele Vergara4Elena Pitotti5Cosimo Neglia6Alessandro Distante7Giampiero Diego Romano8Nicola Di Renzo9Giammarco Surico10Prisco Piscitelli11Michele Maffia12Department of Biological and Environmental Sciences and Technologies, Campus Ecotekne, University of Salento, via Monteroni, 73100 Lecce, ItalyMedical Oncology Unit, “Vito Fazzi” Hospital, 73100 Lecce, ItalyDepartment of Biological and Environmental Sciences and Technologies, Campus Ecotekne, University of Salento, via Monteroni, 73100 Lecce, ItalyDepartment of Biological and Environmental Sciences and Technologies, Campus Ecotekne, University of Salento, via Monteroni, 73100 Lecce, ItalyDepartment of Biological and Environmental Sciences and Technologies, Campus Ecotekne, University of Salento, via Monteroni, 73100 Lecce, ItalyLocal Health Authority ASL Lecce, 73100 Lecce, ItalyEuro Mediterranean Scientific Biomedical Institute (ISBEM), 72100 Brindisi, ItalyEuro Mediterranean Scientific Biomedical Institute (ISBEM), 72100 Brindisi, ItalyMedical Oncology Unit, “Vito Fazzi” Hospital, 73100 Lecce, ItalyMedical Oncology Unit, “Vito Fazzi” Hospital, 73100 Lecce, ItalyMedical Oncology Unit, “Vito Fazzi” Hospital, 73100 Lecce, ItalyLocal Health Authority ASL Lecce, 73100 Lecce, ItalyDepartment of Biological and Environmental Sciences and Technologies, Campus Ecotekne, University of Salento, via Monteroni, 73100 Lecce, ItalyGlycans play a fundamental role in several biological processes, such as cell–cell adhesion, signaling, and recognition. Similarly, abnormal glycosylation is involved in many pathological processes, among which include tumor growth and progression. Several highly glycosylated proteins found in blood are currently used in clinical practice as cancer biomarkers (e.g., CA125, PSA, and CA19-9). The development of novel non-invasive diagnostic procedures would greatly simplify the screening and discovery of pathologies at an early stage, thus also allowing for simpler treatment and a higher success rate. In this observational study carried out on 68 subjects diagnosed with either breast or lung cancer and 34 healthy volunteers, we hydrolyzed the glycoproteins in saliva and quantified the obtained free sugars (fucose, mannose, galactose, glucosamine, and galactosamine) by using high-performance anion-exchange chromatography with pulsed-amperometric detection (HPAEC-PAD). The glycosidic profiles were compared by using multivariate statistical analysis, showing differential glycosylation patterns among the three categories. Furthermore, Receiver Operating Characteristics (ROC) analysis allowed obtaining a reliable and minimally invasive protocol able to discriminate between healthy and pathological subjects.https://www.mdpi.com/2218-1989/11/9/566HPEAC-PADglycoproteinglycomicsglycosylationsalivaearly diagnosis
spellingShingle Andrea Ragusa
Pietrina Romano
Marcello Salvatore Lenucci
Emanuela Civino
Daniele Vergara
Elena Pitotti
Cosimo Neglia
Alessandro Distante
Giampiero Diego Romano
Nicola Di Renzo
Giammarco Surico
Prisco Piscitelli
Michele Maffia
Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
Metabolites
HPEAC-PAD
glycoprotein
glycomics
glycosylation
saliva
early diagnosis
title Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
title_full Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
title_fullStr Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
title_full_unstemmed Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
title_short Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
title_sort differential glycosylation levels in saliva from patients with lung or breast cancer a preliminary assessment for early diagnostic purposes
topic HPEAC-PAD
glycoprotein
glycomics
glycosylation
saliva
early diagnosis
url https://www.mdpi.com/2218-1989/11/9/566
work_keys_str_mv AT andrearagusa differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT pietrinaromano differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT marcellosalvatorelenucci differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT emanuelacivino differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT danielevergara differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT elenapitotti differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT cosimoneglia differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT alessandrodistante differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT giampierodiegoromano differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT nicoladirenzo differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT giammarcosurico differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT priscopiscitelli differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes
AT michelemaffia differentialglycosylationlevelsinsalivafrompatientswithlungorbreastcancerapreliminaryassessmentforearlydiagnosticpurposes